SGLT2 Inhibitors in Patients With ADHF During Ventilator Weaning
Status:
Recruiting
Trial end date:
2030-10-09
Target enrollment:
Participant gender:
Summary
This study will explore the potential benefits of sodium-glucose cotransporter 2 (SGLT2)
inhibitors in preventing cardiac ischemia and cardiopulmonary edema in patients with acute
decompensated heart failure during weaning from ventilators.